{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:59:30Z","timestamp":1791295170164,"version":"4.1.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,8,16]],"date-time":"2012-08-16T00:00:00Z","timestamp":1345075200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Hematol"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/1471-2326-12-10","type":"journal-article","created":{"date-parts":[[2012,8,16]],"date-time":"2012-08-16T14:14:26Z","timestamp":1345126466000},"source":"Crossref","is-referenced-by-count":7,"title":["Estimating the treatment effect from non-randomized studies: The example of reduced intensity conditioning allogeneic stem cell transplantation in hematological diseases"],"prefix":"10.1186","volume":"12","author":[{"given":"Matthieu","family":"Resche-Rigon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Pirracchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Robin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regis Peffault","family":"De Latour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Sibon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lionel","family":"Ades","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Ribaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Paul","family":"Fermand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Thieblemont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9rard","family":"Soci\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Chevret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,8,16]]},"reference":[{"issue":"7192","key":"62_CR1","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1136\/bmj.318.7192.1209","volume":"318","author":"DG Altman","year":"1999","unstructured":"Altman DG, Bland JM: Statistics notes. Treatment allocation in controlled trials: why randomise?. BMJ. 1999, 318 (7192): 1209-","journal-title":"BMJ"},{"issue":"2","key":"62_CR2","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1002\/sim.4780020222","volume":"2","author":"OS Miettinen","year":"1983","unstructured":"Miettinen OS: The need for randomization in the study of intended effects. Stat Med. 1983, 2 (2): 267-271. 10.1002\/sim.4780020222.","journal-title":"Stat Med"},{"issue":"7040","key":"62_CR3","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1136\/bmj.312.7040.1215","volume":"312","author":"N Black","year":"1996","unstructured":"Black N: Why we need observational studies to evaluate the effectiveness of health care. BMJ. 1996, 312 (7040): 1215-1218. 10.1136\/bmj.312.7040.1215.","journal-title":"BMJ"},{"issue":"5","key":"62_CR4","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/S0002-9394(00)00754-6","volume":"130","author":"K Benson","year":"2000","unstructured":"Benson K, Hartz AJ: A comparison of observational studies and randomized, controlled trials. Am J Ophthalmol. 2000, 130 (5): 688-","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"62_CR5","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1001\/jama.297.3.278","volume":"297","author":"TA Stukel","year":"2007","unstructured":"Stukel TA, Fisher ES, Wennberg DE, Alter DA, Gottlieb DJ, Vermeulen MJ: Analysis of observational studies in the presence of treatment selection bias: effects of invasive cardiac management on AMI survival using propensity score and instrumental variable methods. JAMA. 2007, 297 (3): 278-285. 10.1001\/jama.297.3.278.","journal-title":"JAMA"},{"issue":"12","key":"62_CR6","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1038\/sj.leu.2403967","volume":"19","author":"M Aoudjhane","year":"2005","unstructured":"Aoudjhane M, Labopin M, Gorin NC, Shimoni A, Ruutu T, Kolb HJ, Frassoni F, Boiron JM, Yin JL, Finke J, et al: Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older than 50\u2009years of age with acute myeloblastic leukaemia: a retrospective survey from the Acute Leukemia Working Party (ALWP) of the European group for Blood and Marrow Transplantation (EBMT). Leukemia. 2005, 19 (12): 2304-2312. 10.1038\/sj.leu.2403967.","journal-title":"Leukemia"},{"issue":"12","key":"62_CR7","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1182\/blood.V89.12.4531","volume":"89","author":"S Giralt","year":"1997","unstructured":"Giralt S, Estey E, Albitar M, van Besien K, Rondon G, Anderlini P, O'Brien S, Khouri I, Gajewski J, Mehra R, et al: Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy. Blood. 1997, 89 (12): 4531-4536.","journal-title":"Blood"},{"issue":"8","key":"62_CR8","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1200\/JCO.1998.16.8.2817","volume":"16","author":"IF Khouri","year":"1998","unstructured":"Khouri IF, Keating M, Korbling M, Przepiorka D, Anderlini P, O'Brien S, Giralt S, Ippoliti C, von Wolff B, Gajewski J, et al: Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies. J Clin Oncol. 1998, 16 (8): 2817-2824.","journal-title":"J Clin Oncol"},{"issue":"11","key":"62_CR9","doi-asserted-by":"publisher","first-page":"3390","DOI":"10.1182\/blood.V97.11.3390","volume":"97","author":"PA McSweeney","year":"2001","unstructured":"McSweeney PA, Niederwieser D, Shizuru JA, Sandmaier BM, Molina AJ, Maloney DG, Chauncey TR, Gooley TA, Hegenbart U, Nash RA, et al: Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects. Blood. 2001, 97 (11): 3390-3400. 10.1182\/blood.V97.11.3390.","journal-title":"Blood"},{"issue":"4","key":"62_CR10","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1200\/JCO.1996.14.4.1291","volume":"14","author":"N Milpied","year":"1996","unstructured":"Milpied N, Fielding AK, Pearce RM, Ernst P, Goldstone AH: Allogeneic bone marrow transplant is not better than autologous transplant for patients with relapsed Hodgkin's disease. European Group for Blood and Bone Marrow Transplantation. J Clin Oncol. 1996, 14 (4): 1291-1296.","journal-title":"J Clin Oncol"},{"issue":"8","key":"62_CR11","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/sj.bmt.1703891","volume":"31","author":"AJ Peniket","year":"2003","unstructured":"Peniket AJ, Ruiz de Elvira MC, Taghipour G, Cordonnier C, Gluckman E, de Witte T, Santini G, Blaise D, Greinix H, Ferrant A, et al: An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation. Bone Marrow Transplant. 2003, 31 (8): 667-678. 10.1038\/sj.bmt.1703891.","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"62_CR12","doi-asserted-by":"publisher","first-page":"3521","DOI":"10.1182\/blood-2003-04-1205","volume":"102","author":"K van Besien","year":"2003","unstructured":"van Besien K, Loberiza FR, Bajorunaite R, Armitage JO, Bashey A, Burns LJ, Freytes CO, Gibson J, Horowitz MM, Inwards DJ, et al: Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma. Blood. 2003, 102 (10): 3521-3529. 10.1182\/blood-2003-04-1205.","journal-title":"Blood"},{"issue":"18","key":"62_CR13","doi-asserted-by":"publisher","first-page":"3671","DOI":"10.1182\/blood-2009-12-253856","volume":"115","author":"B Sarina","year":"2010","unstructured":"Sarina B, Castagna L, Farina L, Patriarca F, Benedetti F, Carella AM, Falda M, Guidi S, Ciceri F, Bonini A, et al: Allogeneic transplantation improves the overall and progression-free survival of Hodgkin lymphoma patients relapsing after autologous transplantation: a retrospective study based on the time of HLA typing and donor availability. Blood. 2010, 115 (18): 3671-3677. 10.1182\/blood-2009-12-253856.","journal-title":"Blood"},{"issue":"3","key":"62_CR14","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1182\/blood.V91.3.756","volume":"91","author":"S Slavin","year":"1998","unstructured":"Slavin S, Nagler A, Naparstek E, Kapelushnik Y, Aker M, Cividalli G, Varadi G, Kirschbaum M, Ackerstein A, Samuel S, et al: Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. Blood. 1998, 91 (3): 756-763.","journal-title":"Blood"},{"issue":"10","key":"62_CR15","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1038\/sj.leu.2404336","volume":"20","author":"M Mohty","year":"2006","unstructured":"Mohty M, Nagler A, Killmann NM: Reduced-intensity conditioning allogeneic stem cell transplantation: hype, reality or time for a rethink?. Leukemia. 2006, 20 (10): 1653-1654. 10.1038\/sj.leu.2404336.","journal-title":"Leukemia"},{"issue":"11","key":"62_CR16","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1056\/NEJMoa065464","volume":"356","author":"B Bruno","year":"2007","unstructured":"Bruno B, Rotta M, Patriarca F, Mordini N, Allione B, Carnevale-Schianca F, Giaccone L, Sorasio R, Omede P, Baldi I, et al: A comparison of allografting with autografting for newly diagnosed myeloma. N Engl J Med. 2007, 356 (11): 1110-1120. 10.1056\/NEJMoa065464.","journal-title":"N Engl J Med"},{"issue":"9","key":"62_CR17","doi-asserted-by":"publisher","first-page":"3474","DOI":"10.1182\/blood-2005-09-3869","volume":"107","author":"F Garban","year":"2006","unstructured":"Garban F, Attal M, Michallet M, Hulin C, Bourhis JH, Yakoub-Agha I, Lamy T, Marit G, Maloisel F, Berthou C, et al: Prospective comparison of autologous stem cell transplantation followed by dose-reduced allograft (IFM99-03 trial) with tandem autologous stem cell transplantation (IFM99-04 trial) in high-risk de novo multiple myeloma. Blood. 2006, 107 (9): 3474-3480. 10.1182\/blood-2005-09-3869.","journal-title":"Blood"},{"issue":"9","key":"62_CR18","doi-asserted-by":"publisher","first-page":"3914","DOI":"10.1182\/blood-2008-07-168823","volume":"112","author":"P Moreau","year":"2008","unstructured":"Moreau P, Garban F, Attal M, Michallet M, Marit G, Hulin C, Benboubker L, Doyen C, Mohty M, Yakoub-Agha I, et al: Long-term follow-up results of IFM99-03 and IFM99-04 trials comparing nonmyeloablative allotransplantation with autologous transplantation in high-risk de novo multiple myeloma. Blood. 2008, 112 (9): 3914-3915. 10.1182\/blood-2008-07-168823.","journal-title":"Blood"},{"issue":"2","key":"62_CR19","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1200\/JCO.1994.12.2.262","volume":"12","author":"E Archimbaud","year":"1994","unstructured":"Archimbaud E, Thomas X, Michallet M, Jaubert J, Troncy J, Guyotat D, Fiere D: Prospective genetically randomized comparison between intensive postinduction chemotherapy and bone marrow transplantation in adults with newly diagnosed acute myeloid leukemia. J Clin Oncol. 1994, 12 (2): 262-267.","journal-title":"J Clin Oncol"},{"issue":"6","key":"62_CR20","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1182\/blood-2008-07-168625","volume":"113","author":"JJ Cornelissen","year":"2009","unstructured":"Cornelissen JJ, van der Holt B, Verhoef GE, van't Veer MB, van Oers MH, Schouten HC, Ossenkoppele G, Sonneveld P, van Marwijk Kooy M, et al: Myeloablative allogeneic versus autologous stem cell transplantation in adult patients with acute lymphoblastic leukemia in first remission: a prospective sibling donor versus no-donor comparison. Blood. 2009, 113 (6): 1375-1382. 10.1182\/blood-2008-07-168625.","journal-title":"Blood"},{"issue":"6","key":"62_CR21","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1177\/1740774508098326","volume":"5","author":"B Logan","year":"2008","unstructured":"Logan B, Leifer E, Bredeson C, Horowitz M, Ewell M, Carter S, Geller N: Use of biological assignment in hematopoietic stem cell transplantation clinical trials. Clin Trials. 2008, 5 (6): 607-616. 10.1177\/1740774508098326.","journal-title":"Clin Trials"},{"issue":"25","key":"62_CR22","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1056\/NEJM200006223422511","volume":"342","author":"SJ Pocock","year":"2000","unstructured":"Pocock SJ, Elbourne DR: Randomized trials or observational tribulations?. N Engl J Med. 2000, 342 (25): 1907-1909. 10.1056\/NEJM200006223422511.","journal-title":"N Engl J Med"},{"issue":"7116","key":"62_CR23","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1136\/bmj.315.7116.1151","volume":"315","author":"DE Grobbee","year":"1997","unstructured":"Grobbee DE, Hoes AW: Confounding and indication for treatment in evaluation of drug treatment for hypertension. BMJ. 1997, 315 (7116): 1151-1154. 10.1136\/bmj.315.7116.1151.","journal-title":"BMJ"},{"key":"62_CR24","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1136\/jech.2002.006361","volume":"58","author":"MA Hernan","year":"2004","unstructured":"Hernan MA: A definition of causal effect for epidemiological research. J Epidemiol Community Health. 2004, 58: 265-271. 10.1136\/jech.2002.006361. BMJ Publishing Group Ltd","journal-title":"J Epidemiol Community Health"},{"key":"62_CR25","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1177\/0193841X8801200301","volume":"12","author":"PW Holland","year":"1988","unstructured":"Holland PW, Rubin DB: Causal inference in retrospective studies. Eval Rev. 1988, 12: 203-10.1177\/0193841X8801200301.","journal-title":"Eval Rev"},{"issue":"7","key":"62_CR26","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1136\/jech.2004.029496","volume":"60","author":"MA Hernan","year":"2006","unstructured":"Hernan MA, Robins JM: Estimating causal effects from epidemiological data. J Epidemiol Community Health. 2006, 60 (7): 578-586. 10.1136\/jech.2004.029496.","journal-title":"J Epidemiol Community Health"},{"issue":"1","key":"62_CR27","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/biomet\/70.1.41","volume":"70","author":"PR Rosenbaum","year":"1983","unstructured":"Rosenbaum PR, Rubin DB: The central role of the propensity score in observational studies for causal effects. Biometrika. 1983, 70 (1): 41-55. 10.1093\/biomet\/70.1.41.","journal-title":"Biometrika"},{"issue":"5","key":"62_CR28","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1097\/00001648-200009000-00011","volume":"11","author":"JM Robins","year":"2000","unstructured":"Robins JM, Hernan MA, Brumback B: Marginal structural models and causal inference in epidemiology. Epidemiology. 2000, 11 (5): 550-560. 10.1097\/00001648-200009000-00011.","journal-title":"Epidemiology"},{"issue":"476","key":"62_CR29","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1198\/016214506000000023","volume":"101","author":"T Zhiqiang","year":"2006","unstructured":"Zhiqiang T: A distributional approach for causal inference using propensity scores. J Am Stat Assoc. 2006, 101 (476): 1619-1637. 10.1198\/016214506000000023.","journal-title":"J Am Stat Assoc"},{"key":"62_CR30","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/sim.2739","volume":"26","author":"PC Austin","year":"2007","unstructured":"Austin PC: The design versus the analysis of observational studies for causal effects: parallels with the design of randomized trials. Stat Med. 2007, 26: 20-36. 10.1002\/sim.2739.","journal-title":"Stat Med"},{"issue":"4","key":"62_CR31","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1093\/aje\/kwi208","volume":"162","author":"KM Mortimer","year":"2005","unstructured":"Mortimer KM, Neugebauer R, van der Laan M, Tager IB: An application of model-fitting procedures for marginal structural models. Am J Epidemiol. 2005, 162 (4): 382-388. 10.1093\/aje\/kwi208.","journal-title":"Am J Epidemiol"},{"issue":"1","key":"62_CR32","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jclinepi.2009.07.006","volume":"63","author":"PC Austin","year":"2010","unstructured":"Austin PC: Different measures of treatment effect for different research questions. J Clin Epidemiol. 2010, 63 (1): 9-10. 10.1016\/j.jclinepi.2009.07.006.","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"62_CR33","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/bmt.2010.90","volume":"46","author":"L Karlin","year":"2010","unstructured":"Karlin L, Arnulf B, Chevret S, Ades L, Robin M, De Latour RP, Malphettes M, Kabbara N, Asli B, Rocha V, et al: Tandem autologous non-myeloablative allogeneic transplantation in patients with multiple myeloma relapsing after a first high dose therapy. Bone Marrow Transplant. 2010, 46 (2): 250-256.","journal-title":"Bone Marrow Transplant"},{"issue":"19","key":"62_CR34","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1002\/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B","volume":"17","author":"RB D'Agostino Jr","year":"1998","unstructured":"D'Agostino RB: Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med. 1998, 17 (19): 2265-2281. 10.1002\/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B.","journal-title":"Stat Med"},{"issue":"387","key":"62_CR35","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1080\/01621459.1984.10478078","volume":"79","author":"PR Rosenbaum","year":"1984","unstructured":"Rosenbaum PR, Rubin DB: Reducing bias in observational studies using subclassification on the propensity score. J Am Stat Assoc. 1984, 79 (387): 516-524. 10.1080\/01621459.1984.10478078.","journal-title":"J Am Stat Assoc"},{"issue":"19","key":"62_CR36","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.1002\/sim.1903","volume":"23","author":"JK Lunceford","year":"2004","unstructured":"Lunceford JK, Davidian M: Stratification and weighting via the propensity score in estimation of causal treatment effects: a comparative study. Stat Med. 2004, 23 (19): 2937-2960. 10.1002\/sim.1903.","journal-title":"Stat Med"},{"issue":"12","key":"62_CR37","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1093\/aje\/kwj149","volume":"163","author":"MA Brookhart","year":"2006","unstructured":"Brookhart MA, Schneeweiss S, Rothman KJ, Glynn RJ, Avorn J, Sturmer T: Variable selection for propensity score models. Am J Epidemiol. 2006, 163 (12): 1149-1156. 10.1093\/aje\/kwj149.","journal-title":"Am J Epidemiol"},{"issue":"1","key":"62_CR38","doi-asserted-by":"publisher","first-page":"249","DOI":"10.2307\/2533160","volume":"52","author":"DB Rubin","year":"1996","unstructured":"Rubin DB, Thomas N: Matching using estimated propensity scores: relating theory to practice. Biometrics. 1996, 52 (1): 249-264. 10.2307\/2533160.","journal-title":"Biometrics"},{"issue":"1","key":"62_CR39","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.2202\/1557-4679.1146","volume":"5","author":"PC Austin","year":"2009","unstructured":"Austin PC: Type I error rates, coverage of confidence intervals, and variance estimation in propensity-score matched analyses. Int J Biostat. 2009, 5 (1): 1557-4679. 10.2202\/1557-4679.1146. April 2009. http:\/\/dx.crossref.org\/10.2202%2F1557-4679.1146 ,","journal-title":"Int J Biostat"},{"issue":"4","key":"62_CR40","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1002\/sim.2580","volume":"26","author":"PC Austin","year":"2007","unstructured":"Austin PC, Grootendorst P, Anderson GM: A comparison of the ability of different propensity score models to balance measured variables between treated and untreated subjects: a Monte Carlo study. Stat Med. 2007, 26 (4): 734-753. 10.1002\/sim.2580.","journal-title":"Stat Med"},{"issue":"25","key":"62_CR41","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1002\/sim.3697","volume":"28","author":"PC Austin","year":"2009","unstructured":"Austin PC: Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med. 2009, 28 (25): 3083-3107. 10.1002\/sim.3697.","journal-title":"Stat Med"},{"issue":"12","key":"62_CR42","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1002\/sim.2328","volume":"25","author":"PC Austin","year":"2005","unstructured":"Austin PC, Mamdani MM: A comparison of propensity score methods: a case-study estimating the effectiveness of post-AMI statin use. Stat Med. 2005, 25 (12): 2084-2106.","journal-title":"Stat Med"},{"issue":"4","key":"62_CR43","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1198\/000313004X5824","volume":"58","author":"MM Joffe","year":"2004","unstructured":"Joffe MM, Ten Have TR, Feldman HI: Model Selection, Confounder Control, and Marginal Structural Models. Am Stat. 2004, 58 (4): 272-279. 10.1198\/000313004X5824.","journal-title":"Am Stat"},{"issue":"4","key":"62_CR44","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1097\/01.ede.0000222409.00878.37","volume":"17","author":"MA Hernan","year":"2006","unstructured":"Hernan MA, Robins JM: Instruments for causal inference: an epidemiologist's dream?. Epidemiology. 2006, 17 (4): 360-372. 10.1097\/01.ede.0000222409.00878.37.","journal-title":"Epidemiology"},{"issue":"5","key":"62_CR45","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1097\/00001648-200009000-00012","volume":"11","author":"MA Hernan","year":"2000","unstructured":"Hernan MA, Brumback B, Robins JM: Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men. Epidemiology. 2000, 11 (5): 561-570. 10.1097\/00001648-200009000-00012.","journal-title":"Epidemiology"},{"issue":"6","key":"62_CR46","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1093\/aje\/kwn164","volume":"168","author":"SR Cole","year":"2008","unstructured":"Cole SR, Hernan MA: Constructing inverse probability weights for marginal structural models. Am J Epidemiol. 2008, 168 (6): 656-664. 10.1093\/aje\/kwn164.","journal-title":"Am J Epidemiol"},{"key":"62_CR47","volume-title":"Modern epidemiology","author":"KJ Rothman","year":"2008","unstructured":"Rothman KJ, Greenland S, Lash TL: Modern epidemiology. 2008"},{"issue":"398","key":"62_CR48","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1080\/01621459.1987.10478441","volume":"82","author":"PR Rosenbaum","year":"1987","unstructured":"Rosenbaum PR: Model-based direct adjustment. J Am Stat Assoc. 1987, 82 (398): 387-394. 10.1080\/01621459.1987.10478441.","journal-title":"J Am Stat Assoc"},{"key":"62_CR49","volume-title":"R: A Language and Environment for Statistical Computing","author":"Team RDC","year":"2009","unstructured":"Team RDC: R: A Language and Environment for Statistical Computing. 2009, Vienna, Austria: R Foundation for Statistical Computing"},{"issue":"5","key":"62_CR50","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.ahj.2006.06.020","volume":"152","author":"A Ahmed","year":"2006","unstructured":"Ahmed A, Perry GJ, Fleg JL, Love TE, Goff DC, Kitzman DW: Outcomes in ambulatory chronic systolic and diastolic heart failure: a propensity score analysis. Am Heart J. 2006, 152 (5): 956-966. 10.1016\/j.ahj.2006.06.020.","journal-title":"Am Heart J"},{"key":"62_CR51","volume-title":"Modelling survival data in medical research","author":"D Collet","year":"2003","unstructured":"Collet D: Modelling survival data in medical research. 2003, London, UK: Chapman & Hall\/CRC, 2","edition":"2"},{"issue":"25","key":"62_CR52","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1056\/NEJM200006223422507","volume":"342","author":"J Concato","year":"2000","unstructured":"Concato J, Shah N, Horwitz RI: Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med. 2000, 342 (25): 1887-1892. 10.1056\/NEJM200006223422507.","journal-title":"N Engl J Med"},{"issue":"2","key":"62_CR53","doi-asserted-by":"publisher","first-page":"e75","DOI":"10.1016\/j.suronc.2011.12.003","volume":"21","author":"YJ Chang","year":"2012","unstructured":"Chang YJ, Chen LJ, Chung KP, Lai MS: Application of propensity score model to examine the prognostic significance of lymph node number as a care quality indicator. Surg Oncol. 2012, 21 (2): e75-e85. 10.1016\/j.suronc.2011.12.003.","journal-title":"Surg Oncol"},{"issue":"12","key":"62_CR54","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1007\/s00134-010-1991-5","volume":"36","author":"E Gayat","year":"2010","unstructured":"Gayat E, Pirracchio R, Resche-Rigon M, Mebazaa A, Mary JY, Porcher R: Propensity scores in intensive care and anaesthesiology literature: a systematic review. Intensive Care Med. 2010, 36 (12): 1993-2003. 10.1007\/s00134-010-1991-5.","journal-title":"Intensive Care Med"},{"key":"62_CR55","first-page":"1","volume-title":"Ann Hematol","author":"K Oshima","year":"2012","unstructured":"Oshima K, Takahashi W, Asano-Mori Y, Izutsu K, Takahashi T, Arai Y, Nakagawa Y, Usuki K, Kurokawa M, Suzuki K, et al: Intensive chemotherapy for elderly patients with acute myelogeneous leukemia: a propensity score analysis by the Japan Hematology and Oncology Clinical Study Group (J-HOCS). Ann Hematol. 2012, 1-7."},{"key":"62_CR56","volume-title":"Cancer","author":"HK Sanoff","year":"2012","unstructured":"Sanoff HK, Carpenter WR, Freburger J, Li L, Chen K, Zullig LL, Goldberg RM, Schymura MJ, Schrag D: Comparison of adverse events during 5-fluorouracil versus 5-fluorouracil\/oxaliplatin adjuvant chemotherapy for stage III colon cancer: A Population-based analysis. Cancer. 2012"},{"issue":"3","key":"62_CR57","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1023\/A:1020363010465","volume":"2","author":"DB Rubin","year":"2001","unstructured":"Rubin DB: Using propensity scores to help design observational studies: application to the tobacco litigation. Health Services and Outcomes Research Methodology. 2001, 2 (3): 169-188. 10.1023\/A:1020363010465.","journal-title":"Health Services and Outcomes Research Methodology"},{"issue":"3","key":"62_CR58","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1023\/A:1020371312283","volume":"2","author":"K Hirano","year":"2001","unstructured":"Hirano K, Imbens GW: Estimation of causal effects using propensity score weighting: An application to data on right heart catheterization. Health Services and Outcomes Research Methodology. 2001, 2 (3): 259-278. 10.1023\/A:1020371312283.","journal-title":"Health Services and Outcomes Research Methodology"},{"issue":"2","key":"62_CR59","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1053\/j.jvca.2007.12.019","volume":"22","author":"DJ Kor","year":"2008","unstructured":"Kor DJ, Brown MJ, Iscimen R, Brown DR, Whalen FX, Roy TK, Keegan MT: Perioperative statin therapy and renal outcomes after major vascular surgery: a propensity-based analysis. J Cardiothorac Vasc Anesth. 2008, 22 (2): 210-216. 10.1053\/j.jvca.2007.12.019.","journal-title":"J Cardiothorac Vasc Anesth"}],"container-title":["BMC Blood Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2326-12-10\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2326-12-10.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2326-12-10","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2326-12-10.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,12]],"date-time":"2020-07-12T16:46:37Z","timestamp":1594572397000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmchematol.biomedcentral.com\/articles\/10.1186\/1471-2326-12-10"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,16]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["62"],"URL":"https:\/\/doi.org\/10.1186\/1471-2326-12-10","relation":{},"ISSN":["1471-2326"],"issn-type":[{"value":"1471-2326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,16]]},"article-number":"10"}}